Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patients
Open Access
- 1 September 2022
- journal article
- research article
- Published by Majalah Kedokteran Bandung in Majalah Kedokteran Bandung
- Vol. 54 (3), 166-171
- https://doi.org/10.15395/mkb.v54n3.2648
Abstract
Glaucoma is the leading cause of irreversible blindness worldwide. Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) is a new method for treatment for refractory glaucoma with lesser complications than coventional TSCPC. This study aimed to evaluate the effectiveness and safety of MP-TSCPC (IRIDEX IQ810 Laser systems, CA) for refractory glaucoma treatment. This was a retrospective study using data obtained from the medical records of patients who underwent a MP-TSCPC procedure at Cicendo National Eye Hospital from July 2018 to September 2019. The outcomes measured were success rate (IOP decreased ≥30% from baseline with or without anti glaucoma medication at first month follow up) and post-operative complications. Fifty-seven eyes from 56 patients with a mean age of 57 years old underwent MP-TSCPC with 3 month follow up. The mean pre-operative intraocular pressure (IOP) dropped from 51.8 mmHg to 36.0 mmHg at 1 month follow up and 36.8 mmHg at the final follow up, representing an IOP decrease of 31% (1 month) and 28% (3 month). There was also a decrease of anti glaucoma medication usage from 2.51 to 2.16. The overall success rate at 1 month follow up was 49% and only 5% complication were found in this study. MP-TSCPC is safe and effective for lowering IOP and decreasing the need of anti glaucoma -medications in refractory glaucoma case. Further long-term evaluation and comparison to conventional TSCPC are still necessary.Keywords
This publication has 11 references indexed in Scilit:
- Micropulse Versus Continuous Wave Transscleral Cyclophotocoagulation in Refractory Pediatric GlaucomaJournal of Glaucoma, 2018
- Clinical Efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Refractory GlaucomaJournal of Glaucoma, 2018
- Outcome of Micropulse Laser Transscleral Cyclophotocoagulation on Pediatric Versus Adult Glaucoma PatientsJournal of Glaucoma, 2017
- Micropulse Cyclophotocoagulation: Initial Results in Refractory GlaucomaJournal of Glaucoma, 2017
- Update on ciliary body laser proceduresCurrent Opinion in Opthalmology, 2017
- Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucomaLasers in Medical Science, 2015
- Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040Ophthalmology, 2014
- Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory studyClinical & Experimental Ophthalmology, 2014
- Update on results and complications of cyclophotocoagulationCurrent Opinion in Opthalmology, 2013
- Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucomaClinical & Experimental Ophthalmology, 2010